Contact UsInvestorsCareersMediaScienceContact Us
HomeScienceOur Therapy AreasInflammation and Immunology

Inflammation and Immunology

Inflammation is a biological response to potential danger or damage to organs in our body. But with autoimmune diseases such as rheumatoid arthritis, ulcerative colitis and many others, our own immune system becomes dysregulated and turns against our organs.

These conditions may be painful and debilitating, and can take an immense toll on people’s quality of life.

Our scientists are focused on three specific areas; rheumatology, gastroenterology and medical dermatology. Our innovation in the short term is to enable patients to thrive in remission through new immunosuppressives, and in the future improve our understanding of how to promote the restoration of the immune system and tissue health.

Related Content

Pfizer UK and the National Institute for Health Research expand partnership to support innovative research

Pfizer UK and the National Institute for Health Research (NIHR) are expanding their partnership.

Breakthrough Nation II: A bold agenda for change

'Breakthrough Nation II' provides our latest thinking for how industry and government can work better together.

Partnering to support the future leaders in research

National Institute for Health Research (NIHR) and Pfizer UK embark on exciting partnership.


  1. NCBI. Autoimmune responses are directed against self antigens Accessed Nov 2022.
PP-UNP-GBR-2810 / November 2022
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.